Results 71 to 80 of about 7,511 (159)

Long‐term test and retest reliability of clinical vergence testing

Ophthalmic and Physiological Optics, Volume 45, Issue 7, Page 1630-1641, November 2025.
Abstract Purpose To establish long‐term reliability measures for vergence testing in a control population of adolescents. Methods Healthy participants between 12 and 17.5 years with normal binocular vision were recruited from 10 clinical sites. Cover test, near point of convergence (NPC), positive and negative fusional vergences, vergence facility (12∆
Mitchell Scheiman, Aparna Raghuram, Christina Master, Matthew L. Robich, Andrew Toole, Erica R. Shelton, Gayathri Srinivasan, Sophia Marusic, Siva Meiyeppen, Lisa A. Jordan, Tawna L. Roberts, EPICC Study Group, Tawna L. Roberts, Lisa A Jordan, Kristine N. Dalton, Gerald A. Grant, Yaping Joyce Liao, Jason Porter, Laura K. Purcell, Mitchell Scheiman, Mark A. Swanson, Suresh Viswanathan, Lisa A Jordan, Loraine T. Sinnott, Matthew L. Robich, Kimberly J. Shaw, Jill A. Myers, Stacey S. Choi, Jason Porter, Nimesh Patel, Chris Koutures, Jennifer Platt, Aparna Raghuram, Michael O’Brien, Neerali Vyas, Emily Wiecek, Sophia Marusic, Debora Ghosh, Carissa Wu, Christina Master, Lindsey Calandra, Katherine Easby, Anne Mozel, Olivia Podolak, Kathryn Rownd, Melissa Godfrey, Ian McGinnis, Colleen Ford, Kelsy Stenger, Karlie Pollock, Kaitlyn Housel, Angela Chen, Silvia Han, Kristine Huang, Susan M. Parker, Jillian Youngerman, Surbhi Bansal, Natalie Breau, Judith Wu, Allegra Burgher, Cristina Llerena Law, Alessandra Posey, Amar Sayani, Lailah Issac, Ryan Bennett, Katherine Green, Ahmed Riaz, Mitchell Scheiman, Siva Meiyeppen, Tawna Roberts, Gerald Grant, Emily Kraus, Shannon Beres, Heather Moss, Anna Wan, Kristin Slinger, Joellen Leonen, Amber Hu, Gayathri Srinivasan, Christabel Baah, Erin Moix Grieb, Caitlyn Lew, Tyler Vandiver, Kylie Clewes, Surbhi Bansal, Angela Lumba‐Brown, Arvind Balaji, Suresh Viswanathan, Patricia A. Modica, Ashwin Badrinath Pothiadia‐Irungovel, Matthew Vaughn, Catherine McDaniel, Ann Morrison, Douglas Widmer, Michelle Buckland, Erica Shelton, Andrew J. Toole, Nancy Stevens, Mark W. Swanson, Sara Gould, Jenifer Montejo, Laura Ferrill, Erin Swanson‐Kimani, Katherine K. Weise, Zenia Cardona, Kristine N. Dalton, Laura K. Purcell, Tammy Labreche, Julie Shalhoub, Dania Abuleil   +109 more
wiley   +1 more source

Upper eyelid retraction disclosed after edrophonium chloride administration in a patient with Graves' orbitopathy and myasthenia gravis

Clinical Ophthalmology, 2012
Hyera Kang,1,2 Yasuhiro Takahashi,1 Masayoshi Iwaki,1 Shinichi Asamura,3 Hirohiko Kakizaki,11Department of Ophthalmology, Aichi Medical University, Nagakute, Aichi, Japan; 2Department of Ophthalmology, Presbyterian Medical Center, Jeonju, Korea ...
Kang H, Takahashi Y, Iwaki M, Asamura S, Kakizaki H   +4 more
doaj  

Tratamiento de la orbitopatía de Graves [PDF]

, 2019
Nuestro objetivo es realizar un resumen de la patología orbitaria en la enfermedad tiroidea, sus herramientas diagnósticas y las medidas terapéuticas actualizadas, basado en la evidencia científica de la bibliografía específica.
Bustos, Isaías Eduardo
core   +1 more source

Ten Year Outcome of Anti‐Thyroid Drug Treatment for First Episode Graves' Thyrotoxicosis: The Predictive Importance of TRAb

Clinical Endocrinology, Volume 103, Issue 4, Page 612-618, October 2025.
ABSTRACT Objective To establish the risk and time course of recurrent thyrotoxicosis following withdrawal of anti‐thyroid drugs (ATD) and risk factors for recurrence. Design Single‐centre retrospective study. Methods Two hundred and ninety people with a first episode of Graves' thyrotoxicosis, who completed a course of ATD, were included.
Nyo Nyo Z. Tun, Nicola N. Zammitt, Mark W. J. Strachan, Jonathan R. Seckl, Fraser W. Gibb   +4 more
wiley   +1 more source

Patterns of Teprotumumab‐Induced Hearing Dysfunction: A Systematic Review

Otolaryngology–Head and Neck Surgery, Volume 173, Issue 3, Page 539-545, September 2025.
Abstract Objective Hearing loss has been reported after administration of the monoclonal antibody teprotumumab. The purpose of this study was to review available evidence regarding the patterns of teprotumumab‐related ototoxicity. Data Sources PubMed, EMBASE, and Cochrane Library.
Kevin Wong, Priya Arya, Yansy Salmeron, Douglas C. Bigelow, Michael J. Ruckenstein, Shubhasree Banerjee, Madhura Tamhankar, Jason A. Brant, Tiffany P. Hwa   +8 more
wiley   +1 more source

Does thyroid surgery for Graves' disease improve health-related quality of life? [PDF]

, 2012
PURPOSE: Graves' disease can induce alterations of the psychosocial well-being that negatively influence the overall well-being of patients. Among the current treatments, surgery has limited indications, and its impact on the health-related quality of ...
AMODIO, Emanuele, BONVENTRE, Sebastiano, DI PAOLA, Valentina, GULOTTA, Gaspare, MORFINO, Giuditta, PALADINO, Nunzia Cinzia, Scerrino,G   +6 more
core   +1 more source

British Thyroid Association Survey of Graves' Disease Management in the UK

Clinical Endocrinology, Volume 103, Issue 3, Page 376-384, September 2025.
ABSTRACT Background Recent years have seen changes and uncertainties in evidence and guideline recommendations in Graves' disease treatment. To understand the impact of these developments on current practice, we undertook a survey of Graves' disease management in the United Kingdom and compared this to other national and international surveys.
Michael Atkinson, Medha Agrawal, Koteshwara Muralidhara, Prakash Abraham, Bijay Vaidya, Onyebuchi E. Okosieme   +5 more
wiley   +1 more source

Graves′ orbitopathy: Management of difficult cases

Indian Journal of Endocrinology and Metabolism, 2012
Management of Graves′ ophthalmopathy (GO) is based on three pillars: to stop smoking, to restore and maintain euthyroidism, and to treat the eye changes according to severity and activity of GO.
Wilmar M Wiersinga
doaj   +1 more source

Morphometric analysis of eyelid fissure in patients with eyelid retraction in acute stage of dysthyroid orbitopathy after treatment with botulinum toxin type A [PDF]

, 2008
OBJETIVO: Apresentar dados morfométricos da fenda palpebral, antes e após a aplicação da toxina botulínica tipo A em pacientes com retração palpebral na fase aguda da orbitopatia distireoidiana.
COSTA, Patrícia Grativol, MATAYOSHI, Suzana, PEREIRA, Ivana Cardoso, SARAIVA, Fábio Petersen   +3 more
core   +2 more sources

Radiological Activity Score (RAS)—MRI Characteristics in Dysthyroid Optic Neuropathy in a Multi‐Ethnic Thyroid Eye Disease Population

Clinical Endocrinology, Volume 103, Issue 3, Page 385-395, September 2025.
ABSTRACT Purpose Dysthyroid Optic Neuropathy (DON) is a sight threatening and diagnostically challenging complication of Thyroid Eye Disease (TED). We provide a comparative analysis of the MRI features associated between patietnts with and without DON. Methods Anonymised retrospective cohort study of patients with TED over eleven years.
Malik Moledina, Vickie Lee, Kunwar Bhatia, Gitta Madani, Claire Feeney, Nicole George, Nour Houbby, Daisy Metcalf, Natalie Man, Rajni Jain, Ahmad Aziz, Ravi Kumar Lingam   +11 more
wiley   +1 more source